paclitaxel has been researched along with pyrazolanthrone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Koller, E; Marietta, PM; Mingo-Sion, AM; Van Den Berg, CL; Wolf, DM | 1 |
| Chambers, TC; Kolomeichuk, SN; Lyle, CS; Sabapathy, K; Terrano, DT | 1 |
| Hendricks, M; Jesuthasan, S | 1 |
| Huang, H; Lo, WY; Lu, TL; Wang, HJ | 1 |
| Bates, DJ; Eastman, A; Lowrey, CH; Salerni, BL | 1 |
| Ahn, YH; Jee, HG; Kim, HR; Kim, JB; Kim, YJ; Lee, HS; Lee, JH; Lee, M; Park, SY; Yoon, JH; Yu, SJ | 1 |
| Bedalov, CO; Prosperi, JR; Soto, KF; VanKlompenberg, MK | 1 |
| Kitanaka, C; Kurachi, H; Kuramoto, K; Nagase, S; Ohta, T; Okada, M; Sakaki, H; Seino, M; Seino, S; Suzuki, S; Takeda, H; Watarai, H | 1 |
| Budach, W; Hüsemann, LC; Jänicke, RU; Piekorz, RP; Radine, C; Reese, A; Sohn, D | 1 |
12 other study(ies) available for paclitaxel and pyrazolanthrone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells.
Topics: Anthracenes; Apoptosis; Breast Neoplasms; Cell Division; Cell Line, Tumor; DNA Replication; Doxorubicin; G2 Phase; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Mitosis; Oligonucleotides, Antisense; Paclitaxel; Tumor Suppressor Protein p53; Ultraviolet Rays | 2004 |
Distinct signaling pathways of microtubule inhibitors--vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively.
Topics: Active Transport, Cell Nucleus; Animals; Anthracenes; Apoptosis; Cell Line; Enzyme Activation; Gene Expression Regulation, Enzymologic; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Knockout; Microtubules; Paclitaxel; Phosphorylation; Promoter Regions, Genetic; Protein Kinase Inhibitors; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Vinblastine | 2008 |
PHR regulates growth cone pausing at intermediate targets through microtubule disassembly.
Topics: Animals; Anthracenes; Apoptosis Regulatory Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Death-Associated Protein Kinases; Dose-Response Relationship, Drug; Electroporation; Enzyme Inhibitors; Gene Expression Regulation; Green Fluorescent Proteins; Growth Cones; Imidazoles; MAP Kinase Kinase 4; Membrane Proteins; Mice; Mice, Transgenic; Microtubules; Neurons; Nocodazole; Paclitaxel; Phosphorylation; Prosencephalon; Pyridines; Signal Transduction; Spinal Cord; Tubulin Modulators; Zebrafish; Zebrafish Proteins | 2009 |
(-)-Epigallocatechin-3-gallate decreases thrombin/paclitaxel-induced endothelial tissue factor expression via the inhibition of c-Jun terminal NH2 kinase phosphorylation.
Topics: Anthracenes; Catechin; Cells, Cultured; Drug-Eluting Stents; Endothelium, Vascular; Humans; JNK Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Thrombin; Thromboplastin; Transcription Factor RelA | 2010 |
Vinblastine sensitizes leukemia cells to cyclin-dependent kinase inhibitors, inducing acute cell cycle phase-independent apoptosis.
Topics: Anthracenes; Antineoplastic Agents, Phytogenic; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclic N-Oxides; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Drug Synergism; Flavonoids; HL-60 Cells; Humans; Immunoblotting; Indolizines; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Myeloid Cell Leukemia Sequence 1 Protein; Paclitaxel; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyridinium Compounds; U937 Cells; Vinblastine | 2011 |
JNK signaling in hepatocarcinoma cells is associated with the side population upon treatment with anticancer drugs.
Topics: Anthracenes; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Fluorouracil; Humans; Liver Neoplasms; MAP Kinase Kinase 4; MAP Kinase Signaling System; Paclitaxel; Proto-Oncogene Proteins c-jun; Side-Population Cells | 2015 |
APC selectively mediates response to chemotherapeutic agents in breast cancer.
Topics: Adenomatous Polyposis Coli Protein; Animals; Anthracenes; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase 4; Mice; Mice, Transgenic; Paclitaxel; Pyrimidines; src-Family Kinases | 2015 |
Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel.
Topics: Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Ovarian Neoplasms; Paclitaxel | 2016 |
The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner.
Topics: Anthracenes; Butadienes; Caspase 3; Cell Cycle; Cell Death; Cell Line, Tumor; Furans; Humans; Ketones; Microtubules; Mitogen-Activated Protein Kinases; Nitriles; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2020 |